GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Medlive Technology Co Ltd (HKSE:02192) » Definitions » Gross Profit

Medlive Technology Co (HKSE:02192) Gross Profit : HK$274.9 Mil (TTM As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Medlive Technology Co Gross Profit?

Medlive Technology Co's gross profit for the six months ended in Dec. 2023 was HK$159.8 Mil. Medlive Technology Co's gross profit for the trailing twelve months (TTM) ended in Dec. 2023 was HK$274.9 Mil.

Gross Margin % is calculated as gross profit divided by its revenue. Medlive Technology Co's gross profit for the six months ended in Dec. 2023 was HK$159.8 Mil. Medlive Technology Co's Revenue for the six months ended in Dec. 2023 was HK$260.9 Mil. Therefore, Medlive Technology Co's Gross Margin % for the quarter that ended in Dec. 2023 was 61.26%.

Medlive Technology Co had a gross margin of 61.26% for the quarter that ended in Dec. 2023 => Durable competitive advantage

During the past 6 years, the highest Gross Margin % of Medlive Technology Co was 73.17%. The lowest was 59.78%. And the median was 65.62%.


Medlive Technology Co Gross Profit Historical Data

The historical data trend for Medlive Technology Co's Gross Profit can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medlive Technology Co Gross Profit Chart

Medlive Technology Co Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Gross Profit
Get a 7-Day Free Trial 85.89 185.21 245.79 237.57 274.91

Medlive Technology Co Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Gross Profit Get a 7-Day Free Trial Premium Member Only Premium Member Only 130.07 106.96 135.68 115.09 159.81

Competitive Comparison of Medlive Technology Co's Gross Profit

For the Medical Distribution subindustry, Medlive Technology Co's Gross Profit, along with its competitors' market caps and Gross Profit data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Medlive Technology Co's Gross Profit Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Medlive Technology Co's Gross Profit distribution charts can be found below:

* The bar in red indicates where Medlive Technology Co's Gross Profit falls into.



Medlive Technology Co Gross Profit Calculation

Gross Profit is the different between the sale prices and the cost of buying or producing the goods.

Medlive Technology Co's Gross Profit for the fiscal year that ended in Dec. 2023 is calculated as

Gross Profit (A: Dec. 2023 )=Revenue - Cost of Goods Sold
=450.641 - 175.736
=274.9

Medlive Technology Co's Gross Profit for the quarter that ended in Dec. 2023 is calculated as

Gross Profit (Q: Dec. 2023 )=Revenue - Cost of Goods Sold
=260.864 - 101.05
=159.8

Gross Profit for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$274.9 Mil.

Gross Profit is the numerator in the calculation of Gross Margin.

Medlive Technology Co's Gross Margin % for the quarter that ended in Dec. 2023 is calculated as

Gross Margin % (Q: Dec. 2023 )=Gross Profit (Q: Dec. 2023 ) / Revenue (Q: Dec. 2023 )
=(Revenue - Cost of Goods Sold) / Revenue
=159.8 / 260.864
=61.26 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


Medlive Technology Co  (HKSE:02192) Gross Profit Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Medlive Technology Co had a gross margin of 61.26% for the quarter that ended in Dec. 2023 => Durable competitive advantage


Medlive Technology Co Gross Profit Related Terms

Thank you for viewing the detailed overview of Medlive Technology Co's Gross Profit provided by GuruFocus.com. Please click on the following links to see related term pages.


Medlive Technology Co (HKSE:02192) Business Description

Traded in Other Exchanges
N/A
Address
No. 1 Baijialou Chaoyang North Road, E1 Red Manor International Bonded Innovation Park, Chaoyang District, Beijing, CHN
Medlive is a digital healthcare marketing company that produces customized content for pharmaceutical and medical device firms to specifically target physicians through different promotional channels. The company uses in-house and third-party content teams to produce advertising for its clients by profiling the user preferences of the physicians on the platform who drive procurement and prescription decisions. Its platform also provides medical content consisting of third-party research, informal discussions, and medical news articles. The company also operates a minor internet hospital and SaaS solution that help with medical conferences and clinical research. M3, Japan's leading digital healthcare marketing company owns 38.8% of Medlive through a joint venture.
Executives
Fil Limited 2201 Interest of corporation controlled by you
Pandanus Associates Inc. 2201 Interest of corporation controlled by you
Pandanus Partners L.p. 2201 Interest of corporation controlled by you
M3, Inc. 2101 Beneficial owner
Sony Group Corporation 2201 Interest of corporation controlled by you
Tian Liping
Zhang Xiaofeng 2101 Beneficial owner
Liu Lingdi 2101 Beneficial owner
Tian Lixin 2101 Beneficial owner
Brown Brothers Harriman & Co. 2502 Approved lending agent
Fidelity Funds 2101 Beneficial owner
Tiantian Co., Limited

Medlive Technology Co (HKSE:02192) Headlines

No Headlines